ID   CLC13
AC   CVCL_RH19
SY   Chinese Liver Cancer cell line 13
DR   cancercelllines; CVCL_RH19
DR   EGA; EGAS00001001678
DR   GEO; GSM2070050
DR   LIMORE; CLC13
DR   Wikidata; Q54813580
RX   PubMed=27273737;
RX   PubMed=31378681;
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; 2514; CTNNB1; Simple; p.Thr41Ile (c.122C>T); ClinVar=VCV000017587; Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Gly105Asp (c.314G>A); ClinVar=VCV000141114; Zygosity=Unspecified (PubMed=27273737; PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genome sequenced.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=27273737; PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 13
ST   D7S820: 10
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 05-10-23; Version: 11
//
RX   PubMed=27273737; DOI=10.1038/srep27411;
RA   Qiu Z.-X., Zou K.-K., Zhuang L.-P., Qin J.-J., Li H., Li C.,
RA   Zhang Z.-T., Chen X.-T., Cen J., Meng Z.-Q., Zhang H.-B., Li Y.-X.,
RA   Hui L.-J.;
RT   "Hepatocellular carcinoma cell lines retain the genomic and
RT   transcriptomic landscapes of primary human cancers.";
RL   Sci. Rep. 6:27411-27411(2016).
//
RX   PubMed=31378681; DOI=10.1016/j.ccell.2019.07.001;
RA   Qiu Z.-X., Li H., Zhang Z.-T., Zhu Z.-F., He S., Wang X.-J.,
RA   Wang P.-C., Qin J.-J., Zhuang L.-P., Wang W., Xie F.-B., Gu Y.,
RA   Zou K.-K., Li C., Li C., Wang C.-H., Cen J., Chen X.-T., Shu Y.-J.,
RA   Zhang Z., Sun L.-L., Min L.-H., Fu Y., Huang X.-W., Lv H., Zhou H.,
RA   Ji Y., Zhang Z.-G., Meng Z.-Q., Shi X.-L., Zhang H.-B., Li Y.-X.,
RA   Hui L.-J.;
RT   "A pharmacogenomic landscape in human liver cancers.";
RL   Cancer Cell 36:179-193.e11(2019).
//